Key facts
- This page summarizes Kirk Look's Form 4 filing for ONCOLYTICS BIOTECH INC (ONCY).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 13 Feb 2026, 07:00.
Kirk Look - 12 Feb 2026 Form 4 Insider Report for ONCOLYTICS BIOTECH INC (ONCY)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- ONCY
- Reported as of
- 12 Feb 2026
- Net transaction value
- +$10,104
- SEC form
- 4
- Accepted by SEC
- 13 Feb 2026, 07:00:30 UTC
- Prior SEC filing
- 02 Jan 2026
- Next SEC filing
- 03 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kirk Look
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kirk Look filed Form 4 for ONCOLYTICS BIOTECH INC (ONCY) on 13 Feb 2026.
Change
- Previous filing in this sequence was filed on 02 Jan 2026.
- Current net transaction value: +$10,104.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0002103582
Primary reporting owner
Look Kirk
- Relationship
- Chief Financial Officer
- Address
- C/O ONCOLYTICS BIOTECH INC., 4350 EXECUTIVE DRIVE, SUITE 325, SAN DIEGO
- Signature
- /s/ Kirk Look
- Signature date
- 13 Feb 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ONCY
transaction
Common Shares
Purchase
- Transaction value
- $10,104
- Shares
- +12,000
- Change %
- +4.4%
- Price
- $0.8420
- Shares after
- 287,515
- Date
- 12 Feb 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.